The GPMA, which has been working hard to mitigate the impact on the print industry of new licensing rules relating to gamma butyrolactone (GBL) and 1,4-butanediol (BDO), solvents used in some print inks, now anticipates a workable resolution following talks with the Home Office and BEIS on 10 March.
Charles Jarrold, chair of the GPMA (which includes the BPIF, IPA, Picon and BCF) said: “We understand and support the Government’s intent to legislate to prevent the misuse of GBL and BDO but we needed to find a fair, sensible and workable way to do that without being detrimental to the printing industry and other sectors. We appreciate the support we have had from BEIS and from the Home Office, who listened to our feedback and have indicated that they intend to respond in such a way that the graphic arts sector can continue to operate effectively moving forward.”
Phil McMullin, head of sales commercial and industrial printing, added: “Epson has worked in collaboration with GPMA on this matter and is pleased with the progress that has been made so far. The GPMA has lobbied rapidly, with conviction and unity to raise awareness of the unintentional but potential damage the current legislation could bring to the UK print industry. Government recognition of the need to protect our industry, and our customers from the proposed legislation is greatly welcomed and will allow UK print businesses to focus on rebuilding after the pandemic. We will continue to work with them closely to resolve this matter.”
Brett Newman, MD at UK and Ireland Mimaki distributor Hybrid Services, said: “Given the positive direction in which the discussions are heading, I now believe that there is light at the end of the tunnel. Hybrid Services will continue to work alongside other industry suppliers and the GPMA to jointly lobby the government to protect the industry and ensure that there will be minimal impact on businesses within the print and graphic art industries.”